In a regulatory 13D/A filing, RA Capital disclosed that it has increased its stake in Tyra Biosciences (TYRA) to 22.4% from 20.1% reported in March. Shares were up 3% at $10.50 at the conclusion of the afterhours session.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TYRA: